ClinConnect ClinConnect Logo
Search / Trial NCT06862271

Comparison of Caudal Block Combined With General Anesthesia and Penile Block and Intravenous Fentanyl in Pediatric Surgeries

Launched by MIRAY GÖZDE ÖZDEMIR · Mar 3, 2025

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

Pediatric Urologic Surgeries Pediatric Delirium Caudal Block Penile Block Flacc Scale Paed Scale

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for boys aged 4 months to 12 years who are undergoing urogenital surgeries, which are common procedures in children. The researchers want to find out which method works better: a caudal block (a type of regional anesthesia that numbs the lower body) combined with general anesthesia, or a penile block along with intravenous fentanyl (a strong pain medication). By comparing these methods, the team hopes to learn more about how well they control pain after surgery, how quickly patients can walk and urinate afterward, and how they feel overall.

To participate in the study, boys must be between 4 months and 12 years old and scheduled for urogenital surgery. They also need to be generally healthy and able to agree to join the study. Unfortunately, boys with certain health issues, such as bleeding disorders or developmental delays, cannot participate. The study has not started recruiting participants yet, but once it does, those who join can expect to be monitored closely during their surgery and recovery to help the researchers gather important information about the effectiveness of the pain relief methods.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • 4 months - 12 years old male patient
  • Acceptance of participation in the study
  • Patients Planned for Urogenital Surgery
  • ASA I-II Patients
  • Exclusion Criteria:
  • \<4 months, \>12 years male patient
  • Female patient
  • Not accepted to be included in the study
  • ASA status III-IV
  • History of bleeding disorder
  • Spinal cord disease
  • Obstructive sleep apnea
  • Developmental delay
  • Behavioral disorder
  • Allergy to any drug in the protocol

About Miray Gözde özdemir

Miray Gözde Özdemir is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and robust methodologies. With a focus on ethical standards and regulatory compliance, the organization collaborates with healthcare professionals and research institutions to facilitate the development of new therapies across various therapeutic areas. Miray Gözde Özdemir emphasizes transparency and integrity in all aspects of clinical trials, ensuring that participant safety and data integrity remain paramount throughout the research process.

Locations

Yenimahalle, Ankara, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported